Efficacy and Safety of the CG-100 Intraluminal Bypass Device

计划入组 250 人 · 首次发布于 2019 年 12 月 4 日

Evaluation of CG-100 Intraluminal Bypass Device

计划入组 7 人 · 首次发布于 2022 年 12 月 1 日

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

计划入组 30 人 · 首次发布于 2018 年 2 月 6 日

PTM-101

CG-8020+CG-2505

CG'806

PQ Bypass, Inc.

United States

CG Pharmaceuticals, Inc.

United States

CG Oncology, Inc.

United States

Galmed Pharmaceuticals to Acquire Colospan, Creating GI-Focused Medtech Platform Targeting $6 Billion Colorectal Surgery Market

Cretostimogene Shows Promise in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

TARA-002 and Cretostimogene Grenadenorepvec Show Promise in Bladder Cancer